The Impact of Adverse Events on Health Care Resource Utilization, Costs, and Mortality Among Patients Treated with Immune Checkpoint Inhibitors

BACKGROUND: We investigated the association between adverse events (AEs) suspected to be immune‐related and health care resource utilization, costs, and mortality among patients receiving programmed cell death 1/programmed cell death ligand 1 immune checkpoint inhibitor (ICI) monotherapy for urothel...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Saby, Bell, Elizabeth J., Zheng, Ying, Kim, Ruth, White, John, Devgan, Geeta, Smith, Jodi, Lal, Lincy S., Engel‐Nitz, Nicole M., Liu, Frank X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Health Outcomes and Economics of Cancer Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265346/
https://www.ncbi.nlm.nih.gov/pubmed/33955118
http://dx.doi.org/10.1002/onco.13812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265346/
https://www.ncbi.nlm.nih.gov/pubmed/33955118
http://dx.doi.org/10.1002/onco.13812

Ejemplares similares